Atlas Trials

Retrospective Study to Determine Effect of Rebif and Tecfidera on Infections and Lymphocytes

Clinical trial NCT03284970 · COMPLETED

Trial details

NCT number
NCT03284970
Sponsor
EMD Serono Research & Development Institute, Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
Relapsing-Remitting Multiple Sclerosis
Start date
2017-08-23
Primary completion
2018-05-11
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.